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Background/aim: Drug provocation tests (DPTs) are the gold standard method performed at the end of a stepwise approach in a drug
allergy workup. Drug provocation tests are administered as a single drug on a test day. Testing more than one drug in a day is a feasible
option and could be a safe and time- and manpower-saving procedure in well-selected patients. The aim of the present study was to
investigate the efficacy and safety of performing a DPT with two or three alternative drugs in one test day (Hacettepe method).
Materials and methods: Adult patients who were admitted with drug hypersensitivity between August 2010 and December 2016 and
underwent DPTs with the described method were included. The method was based on performing DPTs with two or three different,
alternative drugs on the same test day. Data was obtained from standard drug provocation test forms and from patient files.
Results: A total of 1448 DPTs were performed by the Hacettepe method in 1131 patients. The reaction rate was 5.45% (n = 79), and none
of the reactions were severe. The Hacettepe method saved 19.95 DPTs per month which was a considerable time savings.
Conclusion: In cases of proven drug hypersensitivity reactions, performing a drug provocation test with a combination of two or three
different, alternative drugs instead of one saved time and manpower and was a safe procedure. We recommend implementing this
method in drug allergy workups.
Key words: Adverse drug reaction, drug allergy, drug hypersensitivity, drug provocation test, provocation test

1. Introduction
Drug provocation tests (DPTs) are the gold standard
used to identify the drug responsible for hypersensitivity
reactions (DHRs), and it is usually performed at the end of
a stepwise approach in a drug allergy workup after in vitro
and skin testing, when appropriate [1]. Providing safe drugs
in cases of proven hypersensitivity is vital for patients who
hesitate to take any medication, and in these cases DPT is
performed to prove tolerance [1]. Nonallergist physicians
and even dentists usually hesitate to prescribe medications
to patients with a history of DHRs. Both European and
American position papers recommend performing DPT
with the primary aim of excluding DHR, emphasizing that
it can also be used to confirm diagnosis or to demonstrate
tolerance to an alternative drug [1–4].
Drug provocation tests should be performed at an
allergy clinic under close observation and with one drug
in a day. Drug allergy workups are time consuming
procedures, and patients are scheduled for 2 to 3 test
days, sometimes, even more. We hypothesized that using
alternative drugs and testing 2 to 3 in a day would be a

feasible option and that it would save time and manpower
and remain a safe procedure in well-selected patients.
The Hacettepe method, using double and triple tests,
was previously described and has been performed in our
clinic since September 2002 [5–9]. The aim of the present
study was to present real-life data about the Hacettepe
method and demonstrate that testing more than one,
alternative drug in a single day was safe, and time and
manpower saving.
2. Materials and methods
This was a retrospective data review study conducted
at the Hacettepe University Hospital, Department
of Pulmonology, Division of Allergy and Clinical
Immunology. Adult patients admitted with DHR between
August 2010 and December 2016 who underwent DPT by
the Hacettepe method were included in this study. Data
was obtained from the standard drug provocation test
forms used in our clinic and from patient files.
The criteria required to establish the diagnosis of DHR
were: a reliable clinical history with the culprit drug with
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at least 2 separate reactions and/or positive skin test results
and/or positive DPT with the culprit drug. The drug
provocation test was not performed with either the culprit
drug or the Hacettepe method in cases of pregnancy or
lactation; underlying cardiac, hepatic, or renal disease;
severe and/or life-threatening immune-cytotoxic or
anaphylactic reaction history; and patient refusal of tests
with either the culprit or the method. All included patients
had immediate (<1 h) or delayed (1–6 h) reactions. None
of the patients with maculopapular exanthema, immunecytotoxic reactions, or severe anaphylaxis were tested with
the method.
Written informed consent was obtained before the
procedures. All provocations were performed under the
close observation of at least one allergy specialist and
experienced medical staff. On the test day, patients were
allowed to eat a simple meal with cheese and bread.
Commercially available drugs were used for testing.
Drug test doses were given between 09:00 AM and 12:00
AM at 30-min intervals. When there was no reaction,
the observation period ended at 17:00 PM. Reactions
were treated promptly, and patients were followed until
resolution of all symptoms.
Figure 1 shows how decisions to perform DPT with
an alternative medicine were made. Figure 2 shows the
methodology of the Hacettepe method. Combinations
of tested drugs were based on patient characteristics
and the judgement of the allergist: e.g., two analgesics
(e.g., paracetamol + meloxicam), one analgesic and
2 antibiotics (e.g., paracetamol + clarithromycin +

amoxicillin – clavulanate), 2 antibiotics (e.g., ciprofloxacin
+ tetracycline), or other alternative combinations. Our
aim was to find at least one safe antibiotic and analgesic.
Each drug was given in two divided doses, making a total
of 4 and 6 doses for double and triple tests, respectively.
In order to provide the maximum single dose of a drug,
the maximum single dose of the drug that can be given
at once was divided into 2 equal doses: 500 + 500 mg
for paracetamol; 7.5 + 7.5 mg for meloxicam; 100 + 100
mg for nimesulide; 500 + 500 mg for clarithromycin,
ciprofloxacin, tetracycline, and amoxicillin–clavulanate;
150 + 150 mg for clindamycin; and 200 + 200 mg for
moxifloxacin.
The test result was considered positive when any
objective symptom such as bronchospasm (at least a
15% drop in PEF), naso-ocular reactions, urticaria,
angioedema, and/or anaphylaxis occurred. The test was
considered negative when no reaction occurred at the end
of the follow-up period. Reactions requiring hospitalization
and/or intensive care unit admission and/or adrenalin
injection, Stevens–Johnson syndrome (SJS), drug reaction
with eosinophilia, and systemic symptoms (DRESS) or
toxic epidermal necrolysis (TEN) were considered severe;
reactions requiring a follow-up of more than one day were
classified as moderate; and other reactions that resolved
on test day and did not require further follow-up were
classified as mild.
In the case of an objective reaction, each drug that
may have caused the reaction was tested on a separate day.
However, due to the retrospective nature of the study, each

Figure 1. Decision to perform drug provocation test. *For patients who describe gastrointestinal intolerance with drugs,
double test over triple may be preferred.
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Figure 2. Methodology of Hacettepe method (an example for double test is given).

and every drug in a positive double or triple test could not
be tested in every patient. The patient may have refused
further tests or may not have had enough time to schedule
all the tests. In order to determine total time saved, the
number of actual test days was extracted from the total
number that would have been required, if double and/or
triple tests had not been performed.
Statistical analysis was performed using SPSS for
Windows version 18.0 (SPSS Inc., Chicago, IL, USA).
Categorical variables were expressed as a frequency instead
of versus mean ± SD, for continuous variables.
3. Results
Between August 2010 and December 2016, 1448 DPTs
(1185 double and 263 triple tests) were performed by
the Hacettepe method in 1131 patients; of these patients
800 (70.7 %) were female. Mean total test days for each
patient was 2.4 ± 1.14 (range: 1–6) days. Table 1 shows
the characteristics of patients who underwent at least one
double or triple test.
The number of positive test results which required
further testing was 79 (5.45%). The mean age of the
patients who tested positive was 40.22 ± 13.27 years, and
59 (75%) of these patients were female. Table 2 shows the
reaction characteristics of those 79 patients. The majority
of the reactions were mild or moderate in severity, and no
anaphylaxis occurred; most of the reactions were urticaria
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and/or angioedema (65.8%). The clinical data from 62
patients (out of 79) for accompanying atopic disease and
culprit drugs were available; among these patients 43
(69.4%) had at least one accompanying atopic disease.
Culprit drugs were NSAIDs, antibiotics, and both in 52
(83.9%), 1 (1.6%), and 9 (14.5%) patients, respectively.
Seventy-one reactions in double or triple tests occurred
when combinations of paracetamol, meloxicam, and/
or nimesulide were tested. In the remaining 8, reactions
occurred with a combination of antibiotics, and in 6 out of
8 of these the reaction was gastrointestinal intolerance, not
hypersensitivity.
In 71 patients who tested positive with NSAIDs in
double and/or triple tests, further tests with these drugs
were performed. A drug provocation test was performed
with each single drug on a separate day in 18 (25.4%)
patients, and drugs were tolerated; in 26 patients (36.6%)
at least one but not all of the drugs were tested, and the
tested drugs were tolerated; and in 16 patients (22.5%) the
tested drugs caused a specific reaction when each drug was
tested on a separate test day. A total of 11 (15.5%) patients
did not accept further tests.
If double and/or triple tests had not been used and each
drug had been tested on a separate day, 1516 additional
test days would have been required to prove tolerance to
alternative drugs. Considering the study inclusion period
of 76 months (2280 days), the Hacettepe method saved
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Table 1. Characteristics of 1131 patients tested with Hacettepe method.
n (%)
Female
Age (years, mean, SD)

*

800 (70.7)
40.8 ± 12.62

*

Total test days (mean ± SD, min-max)

2.4 ± 1.14, 1–6

Total number of double and triple test

1448 (100)

Total number of reactions in double and triple test

79 (5.45)

Double test, n (%)
• Antibiotics
• Analgesics
• Combination (antibiotics and analgesics)

1185 (81.8)
• 553 (46.7)
• 600 (50.6)
• 32 (2.7)

Triple test, n (%)
• Antibiotics
• Analgesics
• Combination (antibiotics and analgesics)

263 (18.2)
• 179 (68)
• 78 (29.7)
• 6 (2.3)

Data available in 1090 patients.

19.95 test days per month (additional test days = 1516/
inclusion period = 76 months), which is a considerable
amount of time.
4. Discussion
Although European, American, and most national
guidelines define indications, contraindications, and
methods of drug allergy workup, there are differences
between countries in practice. Performing a DPT with the
culprit drug should be different than performing it with
an alternative drug. If the original reaction is severe, the
indications for DPT should be carefully reviewed, the
possibility of cross-reactions should be considered, and
each test should be performed with a single drug. NSAID
reactions may be of the cross-reactive type, and in these
cases double or triple tests with 2–3 different NSAIDs,
even if the tested NSAIDs are weak COX-1 inhibitors, may
expose patients to increased doses and cause reactions.
However, if the culprit NSAID reaction is an anaphylaxis
and the patient is a single reactor (i.e. has an IgE-mediated
reaction to a single NSAID or NSAID group), double and/
or triple testing with alternative NSAIDs would be a safe
procedure [10,11].
Performing a DPT with alternative drugs to prove
tolerance is generally safe. Drug provocation tests are time
consuming procedures that require a follow-up period
after the last dose of the drug is given. There is general
consensus regarding the contraindications of DPT, whereas
the challenge procedure varies a great deal from one center
to another [12]. If the indication for a DPT is to exclude or
confirm a diagnosis of drug hypersensitivity, DPT should
be performed with a single drug and, depending on the

severity of the culprit reaction, the starting dose should
be 1:10.000 to 1:10 of the therapeutic dose [1]. However,
if the indication is to find an alternative drug, based on
our experience, we recommend beginning with higher
doses; instead of giving 4–5 divided doses, we recommend
2 doses.
In this real-life study featuring a considerable number
of DPTs by the Hacettepe method, we showed that testing
two or three different types of drugs in a single day was
safe and saved time and man-power. The reaction rate
was 5.6%, and most reactions were mild (88%) with no
severe reactions. The Hacettepe method saved 20 test days
per month, and there were fewer total test days for each
patient.
We initially described the method in 84 patients who
were admitted with NSAID hypersensitivity between
September 2002 and July 2004 [5]. Triple combinations
of meloxicam, rofecoxib, celecoxib, benzydamine,
azapropazone, codeine, and paracetamol were tested in a
prospective study design. Although all positive triple tests
were performed on separate days with the same drug in
the same order and with the same dose, the method saved
116 test days. There were 18 reactions (21.4%), and 4 (22%)
revealed no reaction when the tests were repeated using
a single drug on separate days [5]. In this study, NSAID
hypersensitivity was proven in all patients, the drugs tested
were weak COX-1 and COX-2 inhibitors and codeine, and
no severe reactions occurred. In real life, 678 double and/
or triple DPTs with NSAIDs have been performed with
a reaction rate of 10.5% (n: 71), which was lower than
previously reported (21.4%). The possible reason for the
lower reaction rate in real life was the heterogeneity of the
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Table 2. Characteristics of 79 patients that had a reaction on drug
provocation test with Hacettepe method.
n (%)
Female

59 (75)

Age (years, mean, SD)

40.22 ± 13.27

Atopic disease*
• Asthma
• Allergic rhinitis and/or rhinosinusitis
• Chronic urticaria
• None

43 (69.4)
25 (40.3)
35 (56.5)
10 (16.1)
19 (30.6)

Culprit drug*
• NSAIDs
• Antibiotics
• NSAIDs and antibiotics

52 (83.9)
1 (1.6)
9 (14.5)

Reaction on double and triple test
• NSAIDs
• Antibiotics
• Combination of NSAIDs and antibiotics

71 (89.9)
8† (10)
0

Reaction severity
• Mild
• Moderate
• Severe

69 (88)
10 (12)
0

Reaction type
• Gastrointestinal
• Respiratory
• Urticaria with/without angioedema
• Isolated angioedema

7 (8.9)
20 (25.3)
40 (50.6)
12 (15.2)

Data available in 62 patients, †6 gastrointestinal intolerance, 2
urticaria.

*

population; some patients had hypersensitivity to drugs
other than NSAIDs.
In the second study, double and triple tests with
antibiotics were performed in 15, 17, and 21 patients
with antibiotic, antibiotic and NSAID, and NSAID
hypersensitivity, respectively [6]. Patients were
prospectively enrolled between September 2005
and December 2006. Roxithromycin, tetracycline,
ciprofloxacin, ampicillin, clindamycin, and clarithromycin
were used in double or triple combinations as described
[6]. A total of 53 provocations were performed with 4
reactions, and 2 of the reactions did not recur when the
drugs were tested one by one on separate days. However,
mild and acceptable gastrointestinal side effects like
nausea and vomiting were reported to be high (21.9%),
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more specifically with the triple test [6]. We observed that
triple combinations of antibiotics frequently caused mild
nausea, which does not usually require intervention with
antiemetics and resolves by the end of the test day.
The third study was designed to test combinations
of antibiotics and analgesics as a triple test in multidrug
hypersensitive patients, and results were satisfactory with
no severe adverse effects or reactions [7]. In the present
study 38 (5%) double and/or triple tests were performed as
a combination of antibiotics and analgesics, and there were
no reactions recorded.
It was reported that 21% of penicillin-allergic patients
may demonstrate allergy to other groups of antibiotics,
namely quinolones, and previous history of an immediate
hypersensitivity reaction to beta-lactam antibiotics was
a strong risk factor for quinolone hypersensitivity [13].
From this point of view, it would not be a safe to suggest
that the quinolone group of drugs are reliable without
proving tolerance.
Due to its retrospective design, the study has some
limitations. Nevertheless, it provides important data
about the application of the Hacettepe method in real
life. The main limitations include potential underrecording of some of the minor reactions like nausea or
nonspecific itching, and this method of DPT cannot be
recommended for children before proof of safety because
pharmacodynamics and drug interactions in children are
different than those in adults. Another limitation was the
heterogeneity of the study population. We believe that our
study may provide clinicians with a different perspective
for DPT.
In conclusion, drug hypersensitivity reactions are
common and of significant concern for physicians and
patients. When finding a safe alternative drug for a drug
hypersensitive patient is indicated, we recommend a novel
DPT method. After 16 years of experience in applying
the Hacettepe method of DPT, we conclude that it is a
safe and time- and manpower-saving procedure and we
recommend its implementation in drug allergy workups.
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